01 12Pfizer Canada ULC
01 62473026
02 62900322
01 12PALBOCICLIB
01 6CAPSULE
02 6TABLET
01 62023-01-10
02 62034-02-08
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Brand Name : IBRANCE
Patent Number : 2473026
Filing Date : 2003-01-10
Strength per Unit : 75 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Brand Name : IBRANCE
Patent Number : 2473026
Filing Date : 2003-01-10
Strength per Unit : 100 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Brand Name : IBRANCE
Patent Number : 2473026
Filing Date : 2003-01-10
Strength per Unit : 125 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Patent Expiration Date : 2034-02-08
Date Granted : 2019-03-26
Brand Name : IBRANCE
Patent Number : 2900322
Filing Date : 2014-02-08
Strength per Unit : 75 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2034-02-08
Date Granted : 2019-03-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-02-08
Date Granted : 2019-03-26
Brand Name : IBRANCE
Patent Number : 2900322
Filing Date : 2014-02-08
Strength per Unit : 100 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2034-02-08
Date Granted : 2019-03-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-02-08
Date Granted : 2019-03-26
Brand Name : IBRANCE
Patent Number : 2900322
Filing Date : 2014-02-08
Strength per Unit : 125 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2034-02-08
Date Granted : 2019-03-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Brand Name : IBRANCE
Patent Number : 2473026
Filing Date : 2003-01-10
Strength per Unit : 75 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-02-08
Date Granted : 2019-03-26
Brand Name : IBRANCE
Patent Number : 2900322
Filing Date : 2014-02-08
Strength per Unit : 75 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2034-02-08
Date Granted : 2019-03-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Brand Name : IBRANCE
Patent Number : 2473026
Filing Date : 2003-01-10
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-02-08
Date Granted : 2019-03-26
Brand Name : IBRANCE
Patent Number : 2900322
Filing Date : 2014-02-08
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2034-02-08
Date Granted : 2019-03-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
